Cholangiocarcinoma
399
86
110
133
Key Insights
Highlights
Success Rate
72% trial completion
Published Results
45 trials with published results (11%)
Research Maturity
133 completed trials (33% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.8%
51 terminated out of 399 trials
72.3%
-14.2% vs benchmark
5%
19 trials in Phase 3/4
34%
45 of 133 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 133 completed trials
Clinical Trials (399)
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Agnostic Therapy in Rare Solid Tumors
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Evaluation of Skin Tests in Biotherapy Allergies
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers
Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)
Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome